Saturday March 2, 2019

IPF AND AROUND

Chairs: Martin Kolb (Hamilton, ON - Canada), Michael Kreuter (Heidelberg, Germany), Carlo Vancheri (Catania, Italy)

14.00 What we learned from basic science studies on IPF?
Martin Kolb (Hamilton, ON - Canada)

14.20 Cryobiopsy: lesson learned and future perspectives
Alberto Cavazza (Reggio Emilia, Italy)

14.40 The role of imaging in fibrotic lung disease
Maurizio Zompatori (Milan, Italy)

15.00 Comorbidities on IPF: an underestimate issue
Antonella Caminati (Milan, Italy)

15.20 Discussion
 

HOT TOPICS IN FIBROTIC LUNG DISEASE

Chairs: Sergio Harari (Milan, Italy), Venerino Poletti (Forlì, Italy), Ganesh Raghu (Seattle, WA - USA)

15.50 Genetic and epigenetic factors in IPF
Bruno Crestani (Paris, France)

16.10 Hypersensitivity pneumonitis
Toby M. Maher (London, United Kingdom)

16.30 Antifibrotic therapy: only for IPF patients?
Ganesh Raghu (Seattle, WA - USA)

16.50 The therapy of IPF: what’s next?
Michael Kreuter (Heidelberg, Germany)

17.10 Discussion

17.30 Closing remarks